Both in Biotechnology
Amgen vs Halozyme Therapeutics
Over the past year AMGN returned +57.1% and HALO returned +94.8%; their daily moves had a correlation of 0.37.
AMGN +57.1% HALO +94.8%Growth of $1, one year, split-adjusted
| Metric | AMGN | HALO |
|---|---|---|
| Price | $465.45 | $128.95 |
| Market cap | $251.64B | $14.64B |
| Today | −0.12% | −1.50% |
| 1 month | +15.5% | +17.4% |
| 6 months | +43.7% | +99.7% |
| Year to date | +42.2% | +91.6% |
| 1 year | +59.4% | +99.5% |
| Revenue growth (YoY) | +9.5% | +47.7% |
| Gross margin | 72.0% | 83.5% |
| Net margin | 23.6% | 47.8% |
| P/E (TTM) | 28.8× | 35.4× |
| Price / sales | 6.6× | 8.8× |
| Net cash | -$43.31B | -$1.92B |
| Dividend yield | 2.17% | — |
| Volatility (60d) | 33.1% | 27.9% |
| Short % of float | 2.5% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).